Advocacy




more information

Education




more information

Industry News




more information

Members




more information

About VAHO

Founded in 1990, the Virginia Association of Hematologists and Oncologists (VAHO) is the largest oncology professional organization in the state. VAHO comprises a powerful community of oncologists, nurse practitioners, physician assistants, pharmacists, and other multidisciplinary care providers involved in the treatment of patients with cancer.

Events Calendar view all

 March 2026 
SMTWTFS
1234567
891011121314
15161718192021
22232425262728
293031    

Minimal Resident Disease (MRD) as an Endpoint in the Context of Multiple Myeloma

Thu
26
2026
March 26, 2026
6:00PM - 6:45PM EST

Zoom

Learning Objectives 1. Overview of MRD in Multiple Myeloma 2. Surrogate Endpoints in Multiple Myeloma Clinical Development 3. FDA ODAC Decision on Use of MRD Negativity as Accelerated Approval Endpoint 4. Implications of MRD in Clinical Practice 5. Data-Driven Development of CELMoD Agents in Multiple Myeloma 6. Preclinical Data for CELMoD Agents in Multiple Myeloma 7. Overview of Clinical Trial Program for CELMoD Agents in Multiple Myeloma

view event details

2026 Spring Meeting

Thu
16
2026
April 16 - 19, 2026

Omni Homestead

7696 Sam Snead Highway Hot Springs, VA 24445 United States (800) 838-1766

view event details

Industry News view all

03/19/2026

BMS & Microsoft Collaborate on AI-Driven Early Detection of Lung Cancer Initiative

Bristol Myers Squibb and Microsoft announced a collaboration to advance AI-driven early detection of lung cancer by integrating FDA-cleared radiology algorithms into Microsoft’s imaging platforms. The initiative aims to help clinicians identify lung nodules and diagnose cancer earlier, improve workflow efficiency, and expand access to early detection—particularly in underserved and rural communities. By combining oncology expertise with scalable AI infrastructure, the partnership seeks to improve diagnostic accuracy, accelerate follow-up care, and ultimately enhance patient outcomes while addressing disparities in lung cancer detection.


03/19/2026

Update: SB536

Senate Bill 536 (SB 536), initially expanded into a sweeping medical malpractice overhaul that would have significantly increased liability exposure, was scaled back following strong advocacy from physician organizations and stakeholders. The final conference report removed provisions to raise the malpractice cap, expand the statute of limitations, and add prejudgment interest, instead focusing on data collection from insurers to inform future policy decisions. This outcome preserves the current legal framework while setting the stage for more evidence-based malpractice reform discussions in Virginia.


03/12/2026

SB536 Explodes the Medical Malpractice Cap! Oppose Today!

Act Now!

Earlier in the legislative session, Mark Obenshain introduced SB 536, which initially proposed allowing pre-judgment interest to be exempt from Virginia’s medical malpractice cap. As the bill moved through the legislature, it expanded significantly and now proposes more than doubling the malpractice cap—from $2.75 million in 2026 to $6 million starting in 2027. The bill is now headed to a conference committee, where lawmakers could rewrite it further. The Medical Society of Virginia (MSV) is urging physicians and supporters to contact their legislators and oppose any version of the bill that could increase financial pressures on physicians, hospitals, and healthcare providers. MSV argues that large increases to the cap could worsen financial strain on healthcare practices already facing economic challenges.

Corporate Members view all members